Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/30/2015 07/01/2015 07/02/2015 07/06/2015 07/07/2015 Date
16.43(c) 17.08(c) 16.34(c) 17.07(c) 17.25 Last
728 276 529 529 420 982 283 330 239 791 Volume
+1.86% +3.96% -4.33% +4.47% +1.05% Change
More quotes
Financials ($)
Sales 2015 132 M
EBIT 2015 45,7 M
Net income 2015 28,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 153 M
EBIT 2016 59,8 M
Net income 2016 37,9 M
Debt 2016 -
Yield 2016 -
PER 2015 27,31
PER 2016 20,88
Capi. / Sales 2015 5,85x
Capi. / Sales 2016 5,03x
Capitalization 771 M
More Financials
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs in the Americas, Europe and Asia.It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic and... 
Sector
Biotechnology & Medical Research
Calendar
07/08 | 02:00pmPresentation
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on SUCAMPO PHARMACEUTICALS, I
07/02 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at Cantor Fitzge..
07/01 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at Cantor Fitzge..
06/15 China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA(R..
05/29 SUCAMPO PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
05/27 Sucampo Announces Webcast of Its Presentation at the Jefferies 2015 Healthcar..
05/20 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
05/16 SUCAMPO PHARMACEUTICALS : Announces Clinical Data on Lubiprostone to be Presente..
05/15 Sucampo Announces Clinical Data on Lubiprostone to be Presented at Digestive ..
More news
Sector news : Bio Therapeutic Drugs
07:31a INCYTE : and Vanderbilt University Medical Center Establish Multi-Year Oncology ..
07:30a GENMAB A/S : Announces European Regulatory Submission for Ofatumumab as Maintena..
06:16a SHANGHAI RAAS BLOOD PRODUCTS : Controller Kicks Off Holding Expansion
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06/18 Synergy Longs Now Have The Upper Hand
06/05 After Hours Gainers / Losers
05/17 WEEK IN REVIEW : BeiGene Raises $97 Million For Cancer Drugs
05/08 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene's Future, Northwest Bio's Science, And ..
05/07 Sucampo's cobiprostone Fast Track'd for prevention of oral mucositis


Comments 
Advertisement
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions